Display options
Share it on

Iran J Pathol. 2016;11(2):89-96.

The Diagnosis of HIV Infection in Infants and Children.

Iranian journal of pathology

Alireza Abdollahi, Hana Saffar

Affiliations

  1. Dept. of Pathology, Imam Hospital Complex, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Thrombosis Homeostasis Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  2. Dept. of Pathology, Imam Hospital Complex, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 27499768 PMCID: PMC4939637

Abstract

It is estimated that the number of HIV infected children globally has increased from 1.6 million in 2001 to 3.3 million in 2012. The number of children below 15 years of age living with HIV has increased worldwide. Published data from recent studies confirmed dramatic survival benefit for infants started anti-retroviral therapy (ART) as early as possible after diagnosis of HI. Early confirmation of HIV diagnosis is required in order to identify infants who need immediate ART. WHO has designed recommendations to improve programs for both early diagnoses of HIV infection and considering ART whenever indicated? It is strongly recommended that HIV virologocal assays for diagnosis of HIV have sensitivity of at least 95% and ideally greater than 98% and specificity of 98% or more under standardized and validated conditions. Timing of virological testing is also important. Infants infected at or around delivery may take short time to have detectable virus. Therefore, sensitivity of virological tests is lower at birth. In utero HIV infection, HIV DNA or RNA can be detected within 48 h of birth and in infants with peripartum acquisition it needs one to two weeks. Finally it is emphasized that all laboratories performing HIV tests should follow available services provided by WHO or CDC for quality assurance programs. Both clinicians and staffs providing laboratory services need regular communications, well-defined SOPs and nationally validated algorithms for optimal use of laboratory tests. Every country should use assays that have been validated by national reference laboratory.

Keywords: HIV infection; children; diagnosis; infants

References

  1. J Acquir Immune Defic Syndr. 1991;4(2):116-21 - PubMed
  2. J Int AIDS Soc. 2014 Nov 02;17(4 Suppl 3):19696 - PubMed
  3. PLoS One. 2014 Mar 06;9(3):e86461 - PubMed
  4. AIDS. 2003 Feb 14;17(3):331-6 - PubMed
  5. J Acquir Immune Defic Syndr. 1993 Aug;6(8):941-8 - PubMed
  6. AIDS. 2008 Jul 11;22(11):1333-43 - PubMed
  7. BMJ. 2008 Apr 26;336(7650):924-6 - PubMed
  8. J Int AIDS Soc. 2010 Mar 21;13:11 - PubMed
  9. Pediatr Infect Dis J. 1995 Nov;14(11):948-54 - PubMed
  10. Pediatrics. 2007 Nov;120(5):e1134-40 - PubMed
  11. Clin Diagn Lab Immunol. 2000 Jul;7(4):698-9 - PubMed
  12. Arch Med Res. 2005 Jul-Aug;36(4):382-6 - PubMed
  13. AIDS. 2001 Sep 28;15(14):1849-56 - PubMed
  14. J Clin Microbiol. 1997 Nov;35(11):2795-801 - PubMed
  15. MMWR Morb Mortal Wkly Rep. 2014 Feb 21;63(7):158-60 - PubMed
  16. BMC Public Health. 2013 Nov 06;13:1047 - PubMed
  17. J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):332-7 - PubMed
  18. J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):192-5 - PubMed
  19. N Engl J Med. 2008 Nov 20;359(21):2233-44 - PubMed
  20. J Clin Microbiol. 2001 Jan;39(1):29-33 - PubMed
  21. Med J Armed Forces India. 2013 Jul;69(3):218-21 - PubMed
  22. Rev Soc Bras Med Trop. 2014 Jan-Feb;47(1):93-6 - PubMed
  23. Clin Infect Dis. 2003 Jul 1;37(Suppl 1):S25-35 - PubMed
  24. BMC Res Notes. 2014 Dec 04;7:876 - PubMed
  25. Clin Vaccine Immunol. 2006 Jan;13(1):152-5 - PubMed
  26. J Clin Virol. 2002 Aug;25(2):205-16 - PubMed
  27. J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):512-9 - PubMed
  28. Trop Med Int Health. 2014 Aug;19(8):978-87 - PubMed
  29. Pediatrics. 2014 Sep;134(3):e875-9 - PubMed
  30. J Clin Microbiol. 2009 Feb;47(2):459-62 - PubMed
  31. Lancet Infect Dis. 2008 Aug;8(8):477-89 - PubMed
  32. Antivir Ther. 2004 Apr;9(2):179-85 - PubMed
  33. J Clin Microbiol. 2004 Jan;42(1):16-20 - PubMed
  34. PLoS One. 2014 Sep 02;9(9):e106383 - PubMed
  35. Pediatr Infect Dis J. 1994 Feb;13(2):90-4 - PubMed
  36. J Clin Microbiol. 2009 Apr;47(4):1031-6 - PubMed
  37. BMC Pediatr. 2014 Feb 12;14:39 - PubMed
  38. Expert Rev Anti Infect Ther. 2014 Mar;12(3):307-18 - PubMed
  39. Clin Microbiol Infect. 2007 Nov;13(11):1134-6 - PubMed
  40. AIDS Rev. 2002 Apr-Jun;4(2):83-92 - PubMed
  41. J Virol Methods. 2003 Oct;113(1):29-34 - PubMed
  42. J Clin Microbiol. 2003 May;41(5):1888-93 - PubMed
  43. Pediatr Infect Dis J. 2009 Apr;28(4):273-6 - PubMed
  44. JAMA. 2000 Mar 1;283(9):1175-82 - PubMed
  45. J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):e92-4 - PubMed
  46. J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):391-4 - PubMed
  47. Int J STD AIDS. 2002 Mar;13(3):171-3 - PubMed
  48. Pediatrics. 2003 Oct;112(4):e289 - PubMed
  49. Antivir Ther. 2007;12(1):107-13 - PubMed
  50. AIDS. 2006 Jun 12;20(9):1289-94 - PubMed
  51. J Clin Microbiol. 2005 Apr;43(4):1851-7 - PubMed
  52. Pediatr Infect Dis J. 1995 May;14(5):382-7 - PubMed
  53. Lancet. 2003 Dec 20;362(9401):2067-8 - PubMed
  54. Pediatr Infect Dis J. 2004 Feb;23(2):173-6 - PubMed
  55. J Int AIDS Soc. 2014 Feb 14;17:18790 - PubMed
  56. J Virol Methods. 2007 Sep;144(1-2):109-14 - PubMed
  57. J Virol Methods. 2002 May 16;103(2):183-90 - PubMed
  58. AIDS. 2006 Jan 9;20(2):207-15 - PubMed
  59. J Clin Microbiol. 2003 Mar;41(3):1016-22 - PubMed
  60. J Int AIDS Soc. 2014 Nov 03;17:19233 - PubMed
  61. J Acquir Immune Defic Syndr. 2000 Apr 1;23(4):358-60 - PubMed

Publication Types